Doctor Maximilian Lobmeyer
Bayer AG, Wuppertal (Germany)
Metabolism and pharmacokinetic drug interaction profile of vericiguat, a soluble guanylate cyclase stimulator
Event: Heart Failure 2019
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
ESC 365 is supported by
